Overview
Laszlo Gopcsa practices in Pest, Hungary. Mr. Gopcsa is rated as an Experienced expert by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Graft Versus Host Disease (GvHD), Aniridia, COVID-19, Agranulocytosis, and Bone Marrow Transplant.
His clinical research consists of co-authoring 37 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Monoclonal Gammopathy of Undetermined Significance (MGUS).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- AniridiaMr. Gopcsa isAdvanced. Learn about Aniridia.
- Bone Marrow TransplantMr. Gopcsa isAdvanced. Learn about Bone Marrow Transplant.
- Graft Versus Host Disease (GvHD)Mr. Gopcsa isAdvanced. Learn about Graft Versus Host Disease (GvHD).
- Experienced
- Acquired HemophiliaMr. Gopcsa isExperienced. Learn about Acquired Hemophilia.
- Acute Myeloid Leukemia (AML)Mr. Gopcsa isExperienced. Learn about Acute Myeloid Leukemia (AML).
- AgranulocytosisMr. Gopcsa isExperienced. Learn about Agranulocytosis.
- BlepharitisMr. Gopcsa isExperienced. Learn about Blepharitis.
- Blood ClotsMr. Gopcsa isExperienced. Learn about Blood Clots.
- Classical Hodgkin LymphomaMr. Gopcsa isExperienced. Learn about Classical Hodgkin Lymphoma.